Table 6: Hb >12 g/dL and end of treatment (Day 56) from clinical Study 7 (ITT population).

1500 mg IV iron ()1000 mg IV iron () value

(%) patients with Hb >12.0 g/dL265 (24.4%)169 (15.6%)

Hb = hemoglobin; ITT = intent-to-treat.
Data on file, Luitpold Pharmaceuticals, Inc.